| |
|
|
|
CfPA-The Center for Professional Advancement, New Brunswick, NJ
December 11-12, 2018
Who Should Attend?
Because of its comprehensive content, this course should prove most valuable to:
• Regulatory Affairs Professionals
• QA/QC
• Scientists/Laboratory Staff
• Supervisors
• Engineers
• Management
• New Drug Project Management
• Legal Staff
• Manufacturing Personnel
Those who are new to the industry or to their current position and do not have an in-depth knowledge of the FDA and its workings will benefit from this course. The program provides an opportunity for more experienced personnel, including middle and upper management, to update and broaden their knowledge. Course Description
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
| Gary L. Yingling, Esq.; Senior Counsel, Morgan, Lewis & Bockius |
Gary L. Yingling, Esq. is Senior Counsel in the Washington, DC office of Morgan, Lewis & Bockius. His practice focuses on regulatory and legal issues concerning food, drugs, medical devices and cosmetics working with the FDA, USDA Food Safety Inspection service and various states. His work has ranged from ingredient safety questions, preparing INDs, to product labeling with particular interest in clinical research/contract research organization/sponsor matters.
Former president of the Food and Drug Law Institute and Director of the Over-the-Counter (OTC) Drug Review, Mr. Yingling received FDA’s Award of Merit, the agency’s highest award, for his legal and administrative work on the OTC Review. He is a registered pharmacist in Maryland and the District of Columbia.
Mr. Yingling earned a B.S. degree in Pharmacy from the University of North Carolina, a M.S. degree from Purdue University, and his J.D. from Emory University. His court admissions are to the US District Court for the District of Columbia and the US Supreme Court. He is co-author of the Guide to Good Clinical Practice. | Mary L. Richardson; Consultant to the Regulatory Affairs Industry |
Mary L. Richardson is currently a private consultant after her retirement as Vice President Regulatory Affairs at Mission Pharmacal Company. As the VP she oversaw all the company's prescription and OTC drugs, medical devices and dietary supplement production for domestic and international regulatory operations to assure compliance with all applicable requirements. Prior to this industry position, Ms. Richardson worked for twenty-one years with FDA, beginning in the New Jersey district office as a consumer safety officer. She served in the Commissioner's Office of Legislative Affairs in both the congressional oversight areas of drugs and foods and the legislative section which develops and analyzes pending legislation affecting FDA. Ms. Richardson held the position of Deputy Director in the Office of Drug Compliance in the Division of Drug Labeling Compliance for prescription and OTC drugs and as Deputy in the Division of Scientific Investigations, directing FDA activities in the bio research monitoring programs. |
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
jmorbit@cfpa.com
|
|
|
|
|
|
|
|
|